Triggers of Cardiovascular Diseases in Rheumatoid Arthritis

Wang, 2013, Etanercept attenuates collagen-induced arthritis by modulating the association between BAFFR expression and the production of splenic memory B cells, Pharmacol Res, 68, 38, 10.1016/j.phrs.2012.11.003 Young, 2007, Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis, Rheumatology (Oxford), 46, 350, 10.1093/rheumatology/kel253 Kumar, 2007, Causes of death in patients with rheumatoid arthritis: comparison with siblings and matched osteoarthritis controls, J Rheumatol, 34, 1695 Peters, 2009, Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study, Arthritis Rheum, 61, 1571, 10.1002/art.24836 van Halm, 2009, Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation, Ann Rheum Dis, 68, 1395, 10.1136/ard.2008.094151 Shah, 2016, Positive surgical margins increase risk of recurrence after partial nephrectomy for high risk renal tumors, J Urol, 196, 327, 10.1016/j.juro.2016.02.075 Bacon, 2002, Accelerated atherogenesis in autoimmune rheumatic diseases, Autoimmun Rev, 1, 338, 10.1016/S1568-9972(02)00100-3 Owlia, 2012, Cardiac manifestations of rheumatological conditions: a narrative review, ISRN Rheumatol, 10.5402/2012/463620 Mantel, 2017, Association between rheumatoid arthritis and risk of ischemic and nonischemic heart failure, J Am Coll Cardiol, 69, 1275, 10.1016/j.jacc.2016.12.033 Davis, 2011, A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis, Arthritis Rheum, 63, 1497, 10.1002/art.30323 Adlan, 2014, Autonomic function and rheumatoid arthritis: a systematic review, Semin Arthritis Rheum, 44, 283, 10.1016/j.semarthrit.2014.06.003 Yalcin, 2013, Prevalence of metabolic syndrome in Behcet disease: a case-control study in Turkey, Am J Clin Dermatol, 14, 421, 10.1007/s40257-013-0034-8 Voskuyl, 2006, The heart and cardiovascular manifestations in rheumatoid arthritis, Rheumatology (Oxford), 45 Maradit-Kremers, 2005, Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study, Arthritis Rheum, 52, 402, 10.1002/art.20853 Lazzerini, 2014, Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation, Autoimmun Rev, 13, 936, 10.1016/j.autrev.2014.05.007 Masoud, 2017, Sudden cardiac death in patients with rheumatoid arthritis, World J Cardiol, 9, 562, 10.4330/wjc.v9.i7.562 John, 2012, Inflammatory arthritis as a novel risk factor for cardiovascular disease, Eur J Intern Med, 23, 575, 10.1016/j.ejim.2012.06.016 Evrengul, 2004, Heart rate variability in patients with rheumatoid arthritis, Rheumatol Int, 24, 198, 10.1007/s00296-003-0357-5 Crowson, 2005, How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?, Arthritis Rheum, 52, 3039, 10.1002/art.21349 Trelle, 2011, Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis, BMJ, 342, c7086, 10.1136/bmj.c7086 Davis, 2008, The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population, Arthritis Rheum, 58, 2603, 10.1002/art.23798 Francis, 2010, Outcomes in patients with rheumatoid arthritis and myocardial infarction, Am J Med, 123, 922, 10.1016/j.amjmed.2010.05.017 Del Buono, 2018, Interplay of inflammation, oxidative stress and cardiovascular disease in rheumatoid arthritis, Heart, 104, 1991, 10.1136/heartjnl-2018-313313 Johnsson, 2009, Hand deformities are important signs of disease severity in patients with early rheumatoid arthritis, Rheumatology (Oxford), 48, 1398, 10.1093/rheumatology/kep253 Theander, 2017, severe extraarticular manifestations in a community-based cohort of patients with rheumatoid arthritis: risk factors and incidence in relation to treatment with tumor necrosis factor Inhibitors, J Rheumatol, 44, 981, 10.3899/jrheum.161103 Cavalli, 2018, Suppression of inflammation and acquired immunity by IL-37, Immunol Rev, 281, 179, 10.1111/imr.12605 Abutaleb, 2018, Myocarditis in duchenne muscular dystrophy after changing steroids, JAMA Cardiol, 3, 1006, 10.1001/jamacardio.2018.2695 Pironti, 2018, Cardiomyopathy, oxidative stress and impaired contractility in a rheumatoid arthritis mouse model, Heart, 104, 2026, 10.1136/heartjnl-2018-312979 Giles, 2005, Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis, Arthritis Res Ther, 7, 195, 10.1186/ar1814 van Albada-Kuipers, 1986, Coronary arteritis complicating rheumatoid arthritis, Ann Rheum Dis, 45, 963, 10.1136/ard.45.11.963 Mason, 2015, Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions, Eur Heart J, 36, 10.1093/eurheartj/ehu403 von Hundelshausen, 2013, [Chronic inflammation and atherosclerosis], Dtsch Med Wochenschr, 138, 1839 Siscovick, 2010, Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community, Rev Endocr Metab Disord, 11, 53, 10.1007/s11154-010-9133-5 Hollan, 2013, Cardiovascular disease in autoimmune rheumatic diseases, Autoimmun Rev, 12, 1004, 10.1016/j.autrev.2013.03.013 Meune, 2010, High risk of clinical cardiovascular events in rheumatoid arthritis: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis, Arch Cardiovasc Dis, 103, 253, 10.1016/j.acvd.2010.03.007 Sattar, 2003, Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis, Circulation, 108, 2957, 10.1161/01.CIR.0000099844.31524.05 Koopman, 2017, Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis, J Intern Med, 282, 64, 10.1111/joim.12626 Adlan, 2017, Cardiovascular autonomic regulation, inflammation and pain in rheumatoid arthritis, Auton Neurosci, 208, 137, 10.1016/j.autneu.2017.09.003 Lin, 2016, Proarrhythmic risk and determinants of cardiac autonomic dysfunction in collagen-induced arthritis rats, BMC Musculoskelet Disord, 17, 491, 10.1186/s12891-016-1347-6 Manavathongchai, 2013, Inflammation and hypertension in rheumatoid arthritis, J Rheumatol, 40, 1806, 10.3899/jrheum.130394 Stern, 2013, Bidirectional neuro-glial signaling modalities in the hypothalamus: role in neurohumoral regulation, Auton Neurosci, 175, 51, 10.1016/j.autneu.2012.12.009 Lieu, 2020, Loss of dynamic regulation of G protein-coupled receptor kinase 2 by nitric oxide leads to cardiovascular dysfunction with aging, Am J Physiol Heart Circ Physiol, 318, 10.1152/ajpheart.00094.2020 Fu, 2014, A long lasting beta1 adrenergic receptor stimulation of cAMP/protein kinase A (PKA) signal in cardiac myocytes, J Biol Chem, 289, 14771, 10.1074/jbc.M113.542589 Chen, 2018, A Modified compound from paeoniflorin, CP-25, suppressed immune responses and synovium inflammation in collagen-induced arthritis mice, Front Pharmacol, 9, 563, 10.3389/fphar.2018.00563 DeMizio, 2020, Autoimmunity and inflammation link to cardiovascular disease risk in rheumatoid arthritis, Rheumatol Ther, 7, 19, 10.1007/s40744-019-00189-0 Aletaha, 2016, Therapeutic implications of autoantibodies in rheumatoid arthritis, RMD Open, 2, 10.1136/rmdopen-2014-000009 Nell, 2005, Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis, Ann Rheum Dis, 64, 1731, 10.1136/ard.2005.035691 Yan, 2008, Cross-talk between tight and anchoring junctions-lesson from the testis, Adv Exp Med Biol, 636, 234, 10.1007/978-0-387-09597-4_13 Liang, 2008, Pro-apoptotic effects of anti-beta1-adrenergic receptor antibodies in cultured rat cardiomyocytes: actions on endoplasmic reticulum and the prosurvival PI3K-Akt pathway, Autoimmunity, 41, 434, 10.1080/08916930802031710 Staudt, 2007, Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy, J Am Coll Cardiol, 49, 1684, 10.1016/j.jacc.2006.11.051 Golia, 2014, Inflammation and cardiovascular disease: from pathogenesis to therapeutic target, Curr Atheroscler Rep, 16, 435, 10.1007/s11883-014-0435-z Graf, 2009, Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis, PLoS One, 4, e6242, 10.1371/journal.pone.0006242 Weber, 2011, Atherosclerosis: current pathogenesis and therapeutic options, Nat Med, 17, 1410, 10.1038/nm.2538 Kay, 2004, The role of interleukin-1 in the pathogenesis of rheumatoid arthritis, Rheumatology (Oxford), 43 Peiro, 2017, IL-1beta inhibition in cardiovascular complications associated to diabetes mellitus, Front Pharmacol, 8, 363, 10.3389/fphar.2017.00363 Terrell, 2006, Jak/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart, Shock, 26, 226, 10.1097/01.shk.0000226341.32786.b9 Yang, 2004, Mechanism of cardiac depression after trauma-hemorrhage: increased cardiomyocyte IL-6 and effect of sex steroids on IL-6 regulation and cardiac function, Am J Physiol Heart Circ Physiol, 287, H2183, 10.1152/ajpheart.00624.2003 Rose-John, 2006, Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer, J Leukoc Biol, 80, 227, 10.1189/jlb.1105674 Liang, 2009, Myeloperoxidase (MPO) and interleukin-17 (IL-17) plasma levels are increased in patients with acute coronary syndromes, J Int Med Res, 37, 862, 10.1177/147323000903700331 Marder, 2011, Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis, Ann Rheum Dis, 70, 1550, 10.1136/ard.2010.148031 Hall, 2005, Disease modification and cardiovascular risk reduction: two sides of the same coin?, Rheumatology (Oxford), 44, 1473, 10.1093/rheumatology/kei012 Nistala, 2009, Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis, Rheumatology (Oxford), 48, 602, 10.1093/rheumatology/kep028 Sun, 2011, Association between HLA-DRB1, HLA-DRQB1 alleles, and CD4(+)CD28(null) T cells in a Chinese population with coronary heart disease, Mol Biol Rep, 38, 1675, 10.1007/s11033-010-0279-8 Dumitriu, 2009, CD4+ CD28 null T cells in coronary artery disease: when helpers become killers, Cardiovasc Res, 81, 11, 10.1093/cvr/cvn248 Ruggio, 2019, Correlation between CD4(+)CD28(null) T lymphocytes, regulatory T cells and plaque rupture: an optical coherence tomography study in acute coronary syndromes, Int J Cardiol, 276, 289, 10.1016/j.ijcard.2018.08.101 Strassheim, 2019, Role of Inflammatory Cell Subtypes in Heart Failure, J Immunol Res, 10.1155/2019/2164017 Zouggari, 2013, B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction, Nat Med, 19, 1273, 10.1038/nm.3284 Mancini, 2017, Activation of AMP-activated protein kinase rapidly suppresses multiple pro-inflammatory pathways in adipocytes including IL-1 receptor-associated kinase-4 phosphorylation, Mol Cell Endocrinol, 440, 44, 10.1016/j.mce.2016.11.010 Dominguez, 2005, Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes, J Vasc Res, 42, 517, 10.1159/000088261 Mirjafari, 2011, Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study, Arthritis Res Ther, 13, R159, 10.1186/ar3476 Giles, 2015, Insulin resistance in rheumatoid arthritis: disease-related indicators and associations with the presence and progression of subclinical atherosclerosis, Arthritis Rheumatol, 67, 626, 10.1002/art.38986 El-Hini, 2013, Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients, Rheumatol Int, 33, 2283, 10.1007/s00296-013-2714-3 Bacchiega, 2017, Interleukin 6 inhibition and coronary artery disease in a high-risk population: a prospective community-based clinical study, J Am Heart Assoc, 6, 10.1161/JAHA.116.005038 Wei, 2019, Serum retinol-binding protein 4 is associated with insulin resistance in patients with early and untreated rheumatoid arthritis, Joint Bone Spine, 86, 335, 10.1016/j.jbspin.2018.07.002 Pamuk, 2006, Role of insulin resistance in increased frequency of atherosclerosis detected by carotid ultrasonography in rheumatoid arthritis, J Rheumatol, 33, 2447 La Montagna, 2007, Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis, Diab Vasc Dis Res, 4, 130, 10.3132/dvdr.2007.031 Gargiulo, 2014, Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomes, Expert Rev Cardiovasc Ther, 12, 1185, 10.1586/14779072.2014.964687 Dessein, 2004, Glucocorticoids and insulin sensitivity in rheumatoid arthritis, J Rheumatol, 31, 867 Hafstrom, 2007, Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis–a randomized study, J Rheumatol, 34, 1810 Fragoulis, 2020, Cardiovascular risk in rheumatoid arthritis and mechanistic links: from pathophysiology to treatment, Curr Vasc Pharmacol, 18, 431, 10.2174/1570161117666190619143842 Feldmann, 2003, Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases, Nat Med, 9, 1245, 10.1038/nm939 Di Giovine, 1988, Tumour necrosis factor in synovial exudates, Ann Rheum Dis, 47, 768, 10.1136/ard.47.9.768 Radner, 2015, Anti-TNF in rheumatoid arthritis: an overview, Wien Med Wochenschr, 165, 3, 10.1007/s10354-015-0344-y van Mulligen, 2019, Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomized controlled TARA study, Ann Rheum Dis, 78, 746, 10.1136/annrheumdis-2018-214970 Choy, 2009, Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions, Ann Rheum Dis, 68, 460, 10.1136/ard.2008.101964 Daien, 2012, Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis, Ann Rheum Dis, 71, 862, 10.1136/annrheumdis-2011-201148 Mahajan, 2018, Recent advances in the treatment of rheumatoid arthritis, Curr Opin Rheumatol, 30, 231, 10.1097/BOR.0000000000000496 Listing, 2015, Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFalpha inhibitors and rituximab, Ann Rheum Dis, 74, 415, 10.1136/annrheumdis-2013-204021 McInnes, 2014, Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study, Ann Rheum Dis, 73, 124, 10.1136/annrheumdis-2012-202442 Micha, 2011, Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease, Am J Cardiol, 108, 1362, 10.1016/j.amjcard.2011.06.054 Meissner, 2016, Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis, Arthritis Res Ther, 18, 183, 10.1186/s13075-016-1077-z Cho, 2018, Impact of anti-rheumatic treatment on cardiovascular risk in Asian patients with rheumatoid arthritis, Semin Arthritis Rheum, 47, 501, 10.1016/j.semarthrit.2017.08.002 Inoue, 2014, Molecular basis for pharmacokinetics and pharmacodynamics of methotrexate in rheumatoid arthritis therapy, Drug Metab Pharmacokinet, 29, 12, 10.2133/dmpk.DMPK-13-RV-119 Ridker, 2009, Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT), J Thromb Haemost, 7, 332, 10.1111/j.1538-7836.2009.03404.x Shirazi, 2017, Role of Inflammation in Heart Failure, Curr Atheroscler Rep, 19, 27, 10.1007/s11883-017-0660-3 Tsiantoulas, 2018, B Cell-activating factor neutralization aggravates atherosclerosis, Circulation, 138, 2263, 10.1161/CIRCULATIONAHA.117.032790 Kyaw, 2010, Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis, J Immunol, 185, 4410, 10.4049/jimmunol.1000033 Cohen, 2006, Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks, Arthritis Rheum, 54, 2793, 10.1002/art.22025 Emery, 2006, The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial, Arthritis Rheum, 54, 1390, 10.1002/art.21778 Morris-Rosenfeld, 2014, Understanding the role of B cells in atherosclerosis: potential clinical implications, Expert Rev Clin Immunol, 10, 77, 10.1586/1744666X.2014.857602 Kim, 2016, Cardiac physiologic regulation of sub-type specific adrenergic receptors in transgenic mice overexpressing beta1- and beta2-adrenergic receptors, Clin Exp Emerg Med, 3, 175, 10.15441/ceem.16.141 Briasoulis, 2016, The role of inflammation and cell death in the pathogenesis, progression and treatment of heart failure, Heart Fail Rev, 21, 169, 10.1007/s10741-016-9533-z Dinh, 2012, Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis, Circulation, 126, 1256, 10.1161/CIRCULATIONAHA.112.099044 Kumar, 2016, Advancement in contemporary diagnostic and therapeutic approaches for rheumatoid arthritis, Biomed Pharmacother, 79, 52, 10.1016/j.biopha.2016.02.001 Giles, 2016, rheumatoid arthritis pharmacotherapies: do they have anti-atherosclerotic activity?, Curr Rheumatol Rep, 18, 27, 10.1007/s11926-016-0578-8 Ristic, 2010, Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment, Rheumatology (Oxford), 49, 1076, 10.1093/rheumatology/kep456 Gan, 2018, Association of serum lipids with autoantibodies and inflammatory markers in rheumatoid arthritis patients, Clin Chim Acta, 486, 282, 10.1016/j.cca.2018.08.028 Plutzky, 2018, Lipids in RA: is less not necessarily more?, Curr Rheumatol Rep, 20, 8, 10.1007/s11926-018-0715-7